Gilead To Pay $8M To Settle Viread Securities Action
Gilead Sciences Inc. has agreed to pay $8.25 million to settle a securities class action alleging the biopharmaceutical company artificially inflated its stock price by failing to disclose that high sales...To view the full article, register now.
Already a subscriber? Click here to view full article